GENETIC WAR ON CHINA
Becoz China is the enemy of the Odessa-alliance...
This genetic targetting was discussed by OP/Aco...

Biological weapons could be built which target individuals in a specific ethnic group based on their DNA, a report by the University of Cambridge has warned.

viruses are capable of targeting certain individuals with certain racial genetics.

The 2019-nCov (coronavirus) uses ACE2-receptors (enzymes) to get into a cell. The amount of ACE-2-receptors is genetically different in different etnic groups because the amount of ACE2-receptors is variable. Especially Asian males are at great risk.



[link to www.rndsystems.com (secure)]
"ACE-2: The SARS Receptor Identified
In late 2002, reports began to emerge from the Guangdong Province in southern China, of a potentially fatal atypical pneumonia with unknown etiology. Ultimately defined as severe acute respiratory syndrome (SARS), these initial cases were followed by rapid outbreaks throughout Southeast Asia, and according to the World Health Organization (WHO) by June 2003 had infected more than 8400 patients worldwide. A global emergency declared by WHO, and a coordinated international response has thus far succeeded in containing the spread of SARS; however, the potential for new outbreaks still exists. These events have led to the rapid identification and genomic sequencing of the infectious agent, a novel coronavirus (SARS-CoV) phylogenetically distinct from those described to date.1-5 At present, there is no consistently effective treatment for SARS, and scientists are searching for potential vaccines and/or therapeutic agents that specifically target SARS-CoV or host cell components necessary for viral replication. In order to gain access to cells, coronaviruses utilize host receptors that bind with spike (S) proteins extending from the viral envelope.6 A recent study by Li et al. reports that angiotensin-converting enzyme 2 (ACE-2) is the receptor critical for mediating SARS-CoV entry into host cells (Figure 1).7"


List of ACE2 genotype percentage per country:
[link to www.researchgate.net (secure)]


The geographic distribution of the ACE II genotype: A novel finding, September 2007
[link to www.researchgate.net (secure)]
Angiotensin converting enzyme (ACE) gene polymorphism insertion (I) or deletion (D) has been widely studied in different populations, and linked to various functional effects and associated with common diseases. The purpose of the present study was to investigate the relationship between the ACE I/D frequency in different populations and geographic location; ACE I/D allele frequency in the Lebanese population and ACE II genotype contribution to the geographic trend were also identified. Five hundred and seventy healthy volunteers were recruited from the Lebanese population. Genomic DNA was extracted from buccal cells, and amplified by polymerase chain reaction; products were then identified by gel electrophoresis. The frequencies of the different ACE I/D genotypes were determined and tested for Hardy-Weinberg equilibrium (HWE). To assess the relationship between ACE I/D frequency and geographic location, and to identify how the Lebanese population contributes to the geographic trend in ACE I/D frequencies, Eurasian population samples and Asians were incorporated in the analyses from the literature. The frequency of the I allele in the Lebanese population was 27% and the corresponding II genotype was at a frequency of 7.37% (in HWE; P=0.979). The ACE I allele and genotype frequencies show an association with longitude, with frequencies increasing eastwards and westwards from the Middle East.


ACE2
A paper, “The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells”, published on bioRxiv, examined COVID-19 cell entry using pseudoviruses made (using recombinant technology) that
express the COVID-19 spike protein, which is used by COVID-19 to gain entry into cells. The pseudoviruses were made using vesicular stomatitis virus (VSV) particles. The authors of the study evaluated the abilty of these pseudoviruses to enter a variety of human and animal cell lines under different experimental conditions.
Their experiments and analysis found that COVID-19 Spike protein binds to angiotensin-converting enzyme 2 (ACE2), and that it uses a cellular protease called TMPRSS2 to activate, or “prime” viral fusion and entry into cells.
This means that TMPRSS2 might be potentially useful therapeutic target for the treatment and prevention of COVID-19 entry into cells. One such candidate is camostat mesylate, a known TMPRSS2 inhibitor. Camostat mesylate is approved for human use in Japan.
The authors also noted that serum from a convalescent SARS-CoV patient neutralized S-protein mediated entry into cells. This means that survivors of the infection may be a useful source of biologics to help others who are infected survive or avoid critical illness. The rate of critical illess of COVID-19 in China is staggering.

It’s important to note that the COVID-19 Spike protein uses a different cellular entry receptor from MERS-CoV, which uses human DPP4. Also, the seasonal coronavirus uses 229E (human APN), and that other coronaviruses, including SARS and HCoV-NL63, use ACE2 to enter cells. The finding that COVID-2 has especially strong binding capacity to ACE2 is consistent either with recent adaptation for living in humans, or for older adaptation in the wild to a mammal that has ACE2 structures that resemble humans.
ACE2 has other roles in the body has well; gene expression data tell us that it plays a role in the regulation of cardiovascular and renal function, as well as fertility (Refseq).

"The specific D allele frequency found across ethnic groups were 39.1% in Asians, 56.2% in Caucasians, and 60.3% people of African descent. (For those who may not know, the corresponding I allele frequency) would be 100%-D for each ethnic group).

This distribution of genotype and alleles would be a TERRIBLE target for a bioweapon that is alleged to target Asians for obvious reasons: it would end up targeting a huge proportion of the rest of the world, and the “home” population, whichever side targeted people based on their ACE2 genotype."


THE NEW VACCINES ARE NOT A GOOD IDEA!
one way to get hundreds of thousands super sick from a coronavirus is to have sensitized the population with a vaccine containing a spike protein. Why? Because prior animal studies showed high mortality following re-challenge in vaccinated animals.


Genetic bioweapons are weapons designed to target certain ethnic groups. Once released, it would only target those whose genes it was designed to attack. This might seem like the first chapter of a dystopian novel, however, a 2004 report, Biotechnology, Weapons and Humanity II, gave heed that construction of such weapons “is now approaching reality”. The rate of progress in some areas of bioscience is exponential. Which makes 2004 a long time ago.

In 2008 the US government held a congressional committee on, ‘Genetics and other human modification technologies: sensible international regulation or a new kind of arms race?’ The bulk of which discussed advances of in genetics and its potential to be weaponized. They spoke about the using “DNA to create modified infectious agents, new toxins, using genetic DNA techniques”. New bio-weapons.

A testimony to the committee by Richard Hayes, Executive Director, Center for Genetics and Society, elucidated: “we also need to acknowledge that a world still far from having overcome its propensity for racism, xenophobia and warfare, the possibility of a techno-eugenic arms race driven by nationalist fervour cannot be dismissed…in 2003 the Sunshine Project documented nearly a dozen possible uses of genetic science for biowarfare purposes. Including the creation of ethnicity-specific pathogens…we now need to add bioweaponry incorporating human genetic technology to our arms control portfolio.”




xxxK